Skip to main content
. 2004 Nov 1;10(21):3151–3156. doi: 10.3748/wjg.v10.i21.3151

Figure 6.

Figure 6

Levels of soluble FasL in serum from patients with different diseases. Cont: Serum from healthy individuals; IDDM: Serum from patients with IDDM; SLE: Serum from IDDM; RAa: Serum from RA patients with activated stage; Ca-ga: Serum from patients with gastric cancer; Leuk: Serum from patients with leukemia; Shadow bar: Serum level detected by commer-cial sFasL kit. Open bar: Serum level detected by anti-sFasL antibody.